Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New baby wearable aims to track health at home

NCT ID NCT06466148

Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable device called JessieHug for newborns and infants. The goal was to see if parents find it easy to use, if babies tolerate wearing it, and if it collects accurate health data like oxygen levels. About 31 healthy infants participated, and parents used the device at home and completed surveys.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
JessieHug wearable device
What this could lead to
If successful, this device could help parents and doctors monitor infant health more easily at home, potentially aiding in early detection of issues like SIDS.
What could go wrong
This was a small, early feasibility study that was terminated, so results may be limited. The device is not yet proven to prevent or detect any condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

31 people

The number who actually took part.

Started

Apr 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 4 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Healthy neonates and infants, with cohorts defined by the following age ranges: 1. newborn (0 weeks and 0/7 days to 0 weeks and 5/7 days), 2. 2-month (6 weeks and 0/7 days to 11 weeks and 6/7 days), 3. 4-month (14 weeks and 0/7 days to 19 weeks and 6/7 days) 2. Born after 37 0/7 weeks of pregnancy 3. Parent or legal guardian at time of discharge is able to understand and provide consent for participation 4. Parent or legal guardian at time of discharge is willing and able to participate in study procedures for the duration of the study 5. Parent or legal guardian is fluent in English 6. Parent or legal guardian has access to the internet Exclusion Criteria: 1. Low birth weight (\< 2500g) 2. Any transfer out of the well baby nursery for increased level of care, including admission to the NICU or transitional nursery. 3. Clinical indication for prolonged postnatal hospitalization (\>4 days)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sudden Infant Death sudden unexpected infant death

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SIDS

Contacts and locations

Locations

  • NewYork Presbyterian - Weill Cornell Medical Center

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.